Gilles de la Tourette syndrome: Patient's knowledge and concern of adverse effects

Movement Disorders

Volumn 21, Issue 2, 2006, Pages 248-252

  Kompoliti, Katie ^a   Goetz, Christopher G ^a   Morrissey, Mary ^a   Leurgans, Sue ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Dopamine blockers; Neuroleptics; Tardive dyskinesia; Tics; Toxicity

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AMNESIA; ANAMNESIS; APATHY; ARTHRITIS; ARTICLE; ASTHMA; AWARENESS; BODY WEIGHT DISORDER; BONE DEFECT; BREAST DISEASE; COHORT ANALYSIS; COLOR BLINDNESS; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DRUG EXPOSURE; EMOTIONAL DISORDER; FATIGUE; FEMALE; GASTROINTESTINAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HAIR LOSS; HALLUCINATION; HEART DISEASE; HUMAN; IMPOTENCE; JAUNDICE; MAJOR CLINICAL STUDY; MALE; MENSTRUATION DISORDER; PERSONALITY DISORDER; PRIORITY JOURNAL; QUESTIONNAIRE; SEIZURE; SEXUAL DYSFUNCTION; SHORT STATURE; SIDE EFFECT; SOMNOLENCE; TARDIVE DYSKINESIA; THOUGHT DISORDER; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; AWARENESS; BRAIN; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COMORBIDITY; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PATIENT EDUCATION; QUESTIONNAIRES; TOURETTE SYNDROME;

EID: 33644962854     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20680     Document Type: Article

References (7)

1. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
2. Shapiro E, Shapiro AK, Fulop G, et al. Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome. Arch Gen Psychiatry 1989;46:722-730.
3. Onofrj M, Paci C, D'Andreamatteo G, Toma L. Olanzapine in severe Gilles de la Tourette syndrome: a 52-week double-blind cross-over study vs. low-dose pimozide. J Neurol 2000;247:443-446.
4. Bruggeman R, van der Linden C, Buitelaar JK, et al. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001;62:50-56.
5. Silva RR, Munoz DM, Daniel W, Barickman J, Friedhoff AJ. Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives. J Clin Psychiatry 1996;57: 129-135.
6. Lang AE. Update on the treatment of tics. Adv Neurol 2001;85: 355-362.
7. Mesulam MM, Petersen RC. Treatment of Gilles de la Tourette's syndrome: eight-year, practice-based experience in a predominantly adult population. Neurology 1987;37:1828-1833.